Although ectopic expressions of CD70 in solid cancer types and hematopoietic malignancies have been established and applications of neutralizing antibody for CD70-targeted therapeutics have been tested in various mouse tumor models [29, 30, 34, 35], limited studies have reported the association between CD70 expression and the survival rate of cancer patients [36]. Here, CD70 is linked to neoplasm.